Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PMCB compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
PMCB
PharmaCyte Biotech, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
PMCB
PharmaCyte Biotech, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PMCB, solid
AMGN, dashed
PMCB
PharmaCyte Biotech, Inc.
Change
0.35
▼
−7.87%
· post 0.35
Mkt cap
$4.1M
Revenue
—
Revenue
—
AMGN
Amgen Inc
Change
461.49
▼
−3.55%
· post 460.22
Closed
Nov 5 '26
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Nov 5 '26
PMCB
PharmaCyte Biotech, Inc.
vs
AMGN
Amgen Inc
0.35
▼
−7.87%
post 0.35
Price
461.49
▼
−3.55%
post 460.22
$4.1M
Mkt cap
$249.0B
—
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
PMCB
0.35
▼
−7.87%
vs
AMGN
461.49
▼
−3.55%
Closed
Nov 5 '26